|
FY2024
12 months to Apr 28, 2024
|
FY2023
12 months to Dec 31, 2022
|
|
|---|---|---|
| Cash flows from operating activities | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash used in operating activities | ||
| Interest income | ||
| Unrealized gain on short term investments | ||
| Change in fair value of warrant liability | ||
| Warrant issuance expense | ||
| Prepaid expenses | ||
| Accrued expenses | ||
| Income tax payable | ||
| Gain on modification of operating leases | ||
| Depreciation expense | ||
| Non-cash operating lease expense | ||
| Paid-in-kind interest | ||
| Operating lease tenant allowances | ||
| Stock based compensation | ||
| Gain on change in fair value of warrant liabilities and other | ||
| Gain on extinguishment of debt | ||
| Amortization of debt issuance costs | ||
| Impairment loss | ||
| Accounts receivable | ||
| Inventories | ||
| Prepaid expenses and other current assets | ||
| Operating right-of-use asset | ||
| Other long-term assets | ||
| Accounts payable | ||
| Nonrelated Party | ||
| Related Party | ||
| Total accounts payable | ||
| Accrued offering costs | ||
| Accrued franchise tax | ||
| Accrued occupancy costs | ||
| Other accrued liabilities | ||
| Operating lease liabilities | ||
| Net cash used in operating activities | ||
| Cash flows from investing activities | ||
| Investment of cash in Trust Account | ||
| Purchase of property and equipment | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities | ||
| Proceeds from issuance of Units in IPO, net of underwriting fee | ||
| Proceeds from stock option exercises | ||
| Proceeds from warrant exercises | ||
| Proceeds from warrant issuances | ||
| (Payment of) proceeds from promissory note - related party | ||
| Deferred offering costs | ||
| Proceeds from issuance of redeemable convertible preferred stock, net | ||
| Payment of transaction costs related to reverse recapitalization and registration statements | ||
| Principal payments on long-term notes payable | ||
| Proceeds from the Oaktree Tranche 2 Loan | ||
| Debt issuance costs | ||
| Redemption of long-term notes payable | ||
| Proceeds from long-term notes payable, net | ||
| Net cash provided by financing activities | ||
| Net change in cash, cash equivalents and restricted cash | ||
| Cash, cash equivalents and restricted cash - beginning of period | ||
| Cash, cash equivalents and restricted cash - end of period | ||
| Initial fair value of Class A common stock subject to possible redemption | ||
| Remeasurement of Class A common stock subject to possible redemption | ||
| Deferred underwriter fee payable | ||
| Initial measurement of warrant liability | ||
| Supplemental disclosures of cash flow information | ||
| Cash paid for interest | ||
| Cash paid for income taxes | ||
| Supplemental disclosures of non-cash operating, investing and financing activities | ||
| Debt converted | ||
| Redeemable Convertible Preferred Stock | ||
| Common Stock | ||
| Forfeiture of accrued interest in connection with the conversion of long-term notes payable | ||
| Reclassification of liability-classified warrants | ||
| Conversion of stock | ||
| Preferred Stock (as converted to common stock) | ||
| Legacy Pinstripes Common Stock | ||
| Transaction costs incurred in connection with the reverse recapitalization and registration statements but not yet paid | ||
| Transfer of warrants related to business combination | ||
| Increase in operating lease right-of-use assets | ||
| Non-cash finance obligation | ||
| Non-cash capital expenditures included in accounts payable | ||
| Change in the redemption amount of the redeemable convertible preferred stock | ||
| Accretion of cumulative dividends on Series I redeemable convertible preferred stock |
Loading...
